NetScientific plc

("NetScientific" or the "Group")

NetScientific announces departure of Chief Executive Officer

16 January 2015: NetScientific (AIM:NSCI), the biomedical and healthcare technology group, today announces that Farad Azima has been removed from the positions of Chief Executive Officer and a Director of NetScientific with immediate effect. The Board has unanimously agreed to terminate Farad's appointment and thanks him for his notable contributions as the founder of the Group and wishes him the best of success with his future ventures.

The Board has appointed Sir Richard Sykes, Chair of the Board, as Executive Chairman, until a new CEO is appointed. This process will begin with immediate effect and a further announcement will be made in due course. Sir Richard has a vast range of experience in managing companies, having previously been Chairman and Chief Executive of GSK. 

Notes to Editors

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website atwww.NetScientific.net

Contact Details

Liberum (NOMAD and Broker)

Chris Bowman / Christopher Britton

Tel: +44 (0) 20 3100 2000

Instinctif Partners

Melanie Toyne-Sewell / Tim Watson

Tel: +44 (0) 20 7457 2020 Email: netscientific@instinctif.com


This information is provided by RNS
The company news service from the London Stock Exchange
ENDBOAVQLFFEFFFBBV
distributed by